Intellipharmaceutics International Inc. IPCIF
0.15 0.00 (+0.00%)
Nov 25, 2024, 3:00 PM EST
0.15 Day range 0.15
52-week range unavailable
News
defenseworld.net Analyzing Nuvo Pharmaceuticals (OTCMKTS:MRVFF) and Intellipharmaceutics International (OTCMKTS:IPCIF) Valuation and Earnings This table compares Nuvo Pharmaceuticals and Intellipharmaceutics International"s revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income…
defenseworld.net Reviewing Intellipharmaceutics International (OTCMKTS:IPCIF) & Neoleukin Therapeutics (NASDAQ:NLTX) Valuation and Earnings This table compares Neoleukin Therapeutics and Intellipharmaceutics International"s revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income…
accesswire.com Intellipharmaceutics Announces Downgrade to OTC Expert Market TORONTO, ON / ACCESSWIRE / June 14, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI.H) ("Intellipharmaceutics" or the "Company"), announced today that its common stock,…
accesswire.com Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan TORONTO, ON / ACCESSWIRE / March 13, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) - ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the…
accesswire.com Intellipharmaceutics Announces Cease Trade Order TORONTO, ON / ACCESSWIRE / March 6, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the…
accesswire.com Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form TORONTO, ON / ACCESSWIRE / February 26, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the…
accesswire.com Intellipharmaceutics International Inc. Announces Stock Option Grant TORONTO, ON / ACCESSWIRE / February 8, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the…
accesswire.com Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange TORONTO, ON / ACCESSWIRE / January 2, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) - ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the…
accesswire.com Intellipharmaceutics Announces Third Quarter 2023 Results TORONTO, ON / ACCESSWIRE / October 16, 2023 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the…
accesswire.com Intellipharmaceutics Reports Director Election Results TORONTO, ON / ACCESSWIRE / September 14, 2023 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the…
accesswire.com Intellipharmaceutics Announces Closing of CAD$3.85 Million Non-Brokered Private Placement TORONTO, ON / ACCESSWIRE / April 22, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in…
accesswire.com Intellipharmaceutics Announces First Quarter 2021 Results TORONTO, ON / ACCESSWIRE / April 14, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the…
benzinga.com Stocks That Hit 52-Week Highs On Friday 
benzinga.com Stocks That Hit 52-Week Highs On Thursday 
benzinga.com Stocks That Hit 52-Week Lows On Thursday - benzinga.com Stocks That Hit 52-Week Lows On Wednesday